Development of gastro-resistant tablets for the protection and intestinal delivery of Lactobacillus fermentum CECT 5716

International Journal of Pharmaceutics

Volumn 487, Issue 1-2, 2015, Pages 314-319

  Villena, María José Martín ^a   Lara Villoslada, Ferderico ^b   Martínez, María Adolfina Ruiz ^a   Hernández, María Encarnación Morales ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Lactalis Puleva   (Spain)

Author keywords

Lactobacillus fermentum; Probiotics; Protection; Tablets

Indexed keywords

ALGINIC ACID; CELLACEFATE; EUDRAGIT; EXCIPIENT; METHYLCELLULOSE; PROBIOTIC AGENT; ENTERIC COATED TABLET; METHYLMETHACRYLATE-METHACRYLIC ACID COPOLYMER; POLYMETHACRYLIC ACID DERIVATIVE;

ARTICLE; DRUG FORMULATION; DRUG STABILITY; LACTOBACILLUS FERMENTUM; PRIORITY JOURNAL; TABLET; TABLET COMPRESSION; TABLET DISINTEGRATION; BACTERIAL COUNT; DRUG DELIVERY SYSTEM; ENTERIC COATED TABLET; HUMAN; INTESTINE; MEDICINAL CHEMISTRY; METABOLISM;

CHEMISTRY, PHARMACEUTICAL; COLONY COUNT, MICROBIAL; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EXCIPIENTS; HUMANS; INTESTINES; LACTOBACILLUS FERMENTUM; POLYMETHACRYLIC ACIDS; PROBIOTICS; TABLETS, ENTERIC-COATED;

EID: 84928492141     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.03.078     Document Type: Article

References (19)

1. R. Arroyo, V. Martín, A. Maldonado, E. Jiménez, L. Fernández, and J.M. Rodríguez Treatment of infectious mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk Clin. Infect. Dis. 50 2010 1551 1558
2. E.S. Chan, and Z. Zhang Encapsulation of probiotic bacteria Lactobacillus acidophilus by direct compression Trans. IChemE 80 Part C 2002 78 82
3. E.S. Chan, and Z. Zhang Bioencapsulation by compression coating of probiotic bacteria for their protection in an acidic medium Process Biochem. 40 2005 3346 3351
4. FAO/WHO, 2001. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report. Available at: http://www.who.int/foodsafety/publications/fs-management/en/probiotics.pdf (accessed 15.12.14).
5. M. Gil-Campos, M. López Á, M.V. Rodriguez-Benítez, J. Romero, I. Roncero, M.D. Linares, J. Maldonado, E. López-Huertas, R. Berwind, K.L. Ritzenthaler, V. Navas, C. Sierra, L. Sempere, A. Geerlings, J.A. Maldonado-Lobón, A.D. Valero, F. Lara-Villoslada, and M. Olivares Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial Pharmacol 65 2012 231 238
6. K. Kailasapathy Microencapsulation of probiotic bacteria: technology and potential applications Curr. Issues Intest. Microbiol. 3 2002 39 48
7. K. Kailasapathy, and J. Chin Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp Immunl. Cell Biol. 78 2000 80 88
8. S. Klayraung, H. Viernstein, and S. Okanogi Development of tablets containing probiotics: effects of formulation and processing on bacterial viability Int. J. Pharm. 370 2009 54 60
9. J. Maldonado, F. Cañabate, L. Sempere, F. Vela, A.R. Sánchez, E. Narbona, E. López-Huertas, A. Geerlings, A.D. Valero, M. Olivares, and F. Lara-Villoslada Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants J. Pediatr. Gastr. Nutr. 54 2012 55 61
10. J. Mañé, V. Lorén, E. Pedrosa, I. Ojanguren, J. Xaus, E. Cabré, E. Domènech, and M.A. Gassull Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice Inflamm. Bowel Dis. 15 2009 1155 1163
11. C. Muller, V. Mazel, C. Dausset, V. Busignies, S. Bornes, A. Nivoliez, and P. Tchoreloff Study of the Lactobacillus rhamnosus Lcr35® properties after compression and proposition of a model to predict tablet stability Eur. J. Pharm. Biopharm. 88 2014 787 794
12. E.J. Plumpton, P. Gilbert, and J.T. Fell The survival of microorganisms during tabletting Int. J. Pharm. 30 1986 241 246
13. J.-F. Poulin, R. Caillard, and M. Subirade β-Lactoglobulin tablets as a suitable vehicle for protection and intestinal delivery of probiotic bacteria Int. J. Pharm. 405 2011 47 54
14. M. Saarela, G. Mogensen, R. Fondén, J. Mätö, and T. Mattila-Sandholm Probiotic bacteria: safety, functional and technological properties J. Biotechnol. 84 2000 197 215
15. M.E. Sánchez, M.A. Ruiz, and M.E. Morales Microorganismos probióticos y salud Ars Pharm. 56 2015 45 59
16. V.P. Singh, J. Sharma, S. Babu, and A. Rizwanulla Singla Role of probiotics in health and disease: a review J. Pak. Med. Assoc. 63 2013 253 257
17. M. Stadler, and H. Viernstein Optimization of a formulation containing viable lactic acid bacteria Int. J. Pharm. 256 2003 117 122
18. C.G. Vinderola, N. Bailo, and J.A. Reinheimer Survival of probiotic microflora in Argentinian yoghurts during refrigerated storage Food Res. Int. 33 2 2000 97 102
19. J.P. Sousa e Silva, S.C. Sousa, P. Costa, E. Cerdeira, M.H. Amaral, J. Sousa Lobo, A.M. Gomes, M.M. Pintado, D. Rodrigues, T. Rocha-Santos, and A.C. Freitas Development of probiotic tablets using microparticles: viability studies and stability studies AAPS Pharm. Sci. Tech. 14 2013 121 127